Table 7.
Comparison of Hospital Anxiety and Depression Scale (depression) between baseline and follow-up in patients of benign breast disease (disease and symptom wise)
| HADS depression score | Baseline, n (%) | Follow-up, n (%) | P |
|---|---|---|---|
| Fibroadenosis (n=30) | |||
| 0- 7 | 24 (80.0) | 25 (83.3) | 0.186* |
| 8- 10 | 4 (13.3) | 3 (10.0) | |
| 11- 21 | 2 (6.7) | 2 (6.7) | |
| Median (IQR)* | 6.0 (4.0−9.0) | 5.0 (3.0−9.0) | |
| Fibroadenoma (n=28) | |||
| 0- 7 | 10 (35.7) | 21 (75.0) | 0.040* |
| 8- 10 | 12 (42.8) | 3 (10.7) | |
| 11- 21 | 6 (21.5) | 4 (14.3) | |
| Median (IQR)* | 6.50 (4.75−9.0) | 4.50 (2.0−6.25) | |
| Both# (n=7) | |||
| 0- 7 | 4 (57.1) | 6 (85.7) | 0.107* |
| 8- 10 | 1 (14.3) | 1 (14.3) | |
| 11- 21 | 2 (28.6) | 0 (0) | |
| Median (IQR)* | 7.0 (4.0-9.0) | 5.0 (2.0−5.0) | |
| Others$ (n=35) | |||
| 0- 7 | 16 (75.6) | 26 (74.2) | 0.005* |
| 8- 10 | 6 (17.1) | 3 (8.6) | |
| 11- 21 | 13 (37.3) | 6 (17.2) | |
| Median (IQR)* | 7.50 (6.75−9.25) | 3.50 (3.0−5.25) | |
| Breast lump (n=55) | |||
| 0- 7 | 29 (52.7) | 45 (81.8) | <0.001* |
| 8- 10 | 17 (30.9) | 4 (7.3) | |
| 11- 21 | 9 (16.4) | 6 (10.9) | |
| Median (IQR)* | 7.0 (5.0−10.0) | 5.0 (3.0−6.0) | |
| Nipple discharge (n=9) | |||
| 0- 7 | 3 (33.3) | 7 (77.8) | 0.108* |
| 8- 10 | 4 (44.4) | 2 (22.2) | |
| 11- 21 | 2 (22.2) | 0 (0) | |
| Median (IQR)* | 8.0 (7.0−10.50) | 5.0 (4.0−7.50) | |
| Mastalgia (n=70) | |||
| 0- 7 | 46 (65.7) | 53 (75.7) | 0.025* |
| 8- 10 | 14 (20.0) | 8 (11.4) | |
| 11- 21 | 10 (14.3) | 9 (12.9) | |
| Median (IQR)* | 6.0 (4.0−9.0) | 5.0 (3.0−7.25) |
*0.186 P value< 0.05 Significant. #Both=Fibroadenosis + Fibroadenoma, $Others=Nipple discharge + mastalgia + chronic breast abscess + duct ectasia. HADS: Hospital Anxiety and Depression Scale, IQR: Interquartile range